![]() |
|
|

*
United States Department of Agriculture, Grand Forks Human Nutrition Research Center and
Department of Surgery, University of North Dakota, Grand Forks, North Dakota 58202-9034.
3To whom correspondence should be addressed.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: copper manganese iron aberrant crypt foci superoxide dismutase rats
| INTRODUCTION |
|---|
|
|
|---|
Superoxide dismutases are metalloenzymes that play a vital role in the
protection of aerobic cells against oxygen toxicity (Fridovich, 1975
). In eukaryotic cells, there are two main intracellular
forms of this enzyme. The first contains both copper and zinc (CuZnSOD)
and is found in the cytosol (McCord and Fridovich 1969
),
and the second contains manganese (MnSOD) and is found mainly in the
mitochondria (Weisiger and Fridovich 1973
). Altered
activities of superoxide dismutase were shown to be important in
multistage carcinogenesis of both rodents and humans. When compared to
their appropriate normal cell counterparts, tumor cells are almost
always low in MnSOD and CuZnSOD activity (Sun 1990
).
This observation was made in a number of different cell types and is
independent of the mechanism of cell transformation (Marlens et al. 1985
, McCormick et al. 1991
, Oberley et al. 1978
, Sun et al. 1993
). Furthermore,
increased amounts of superoxide dismutase were shown to be protective
against cancer. The addition of exogenous superoxide dismutase has led
to the inhibition of oncogenic transformation induced by X-rays
both in vitro and in vivo (Petkau et al. 1975
,
St. Clair et al. 1992
), and transgenic mice
overexpressing MnSOD are resistant to chemically induced skin
carcinogenesis (Oberley and Oberley 1997
).
Dietary factors are potential modulators of both MnSOD and CuZnSOD
activity. Heart MnSOD activity in rats is significantly reduced in rats
fed deficient dietary manganese compared to those fed adequate or high
dietary manganese (Davis et al. 1990 and 1992a
).
Ingestion of high amounts of dietary iron significantly decreased heart
and colonic mucosa MnSOD activities (Davis et al. 1990 and 1992a
, Kuratko 1997
). Similarly,
lymphocyte MnSOD activity in women was significantly affected by
dietary manganese and iron (Davis and Greger 1992
,
Davis et al. 1992b
).
The relationship between dietary iron and MnSOD activity may have
implications for cancer susceptibility. Four epidemiologic studies have
shown an increased cancer risk in patients with larger iron stores than
in those with small iron stores (Reizenstein 1991
), and
hemochromatosis was associated with iron-induced carcinogenesis
(Toyokuni 1996
). In fact, the major cause of death in
hemochromatosis patients is hepatocellular carcinoma (Niedereau et al. 1985
). A dose-response relationship was also
observed between serum ferritin concentrations and colon adenocarcinoma
risk (Nelson et al. 1994
). High amounts of dietary iron
were shown to be carcinogenic in experimental animals (Toyokuni 1996
). However, the literature examining the effect of dietary
iron on cancer susceptibility is inconsistent. Two animal studies
(Lai et al. 1997
, Soyars and Fischer 1998
) have shown no increased risk of colon cancer with
increased dietary iron, and several epidemiological studies have not
found a positive correlation between iron stores and colon cancer risk
(Tseng et al. 1996
, Ullen et al. 1997
).
Dietary iron can catalyze the production of reactive oxygen species,
which may be proximate carcinogens (Reizenstein 1991
).
Thus, high concentrations of dietary iron will lead to an increased
need for antioxidant protection. However, MnSOD activity is down
regulated in hepatic iron overload (Zhao et al. 1995
).
People with iron overload have an increased need for MnSOD activity,
but decreased enzyme available. High dietary iron was shown to increase
the incidence of colon cancer in human subjects; however, no one has
investigated whether this is a result of depressed MnSOD activity and
whether high dietary iron would interact with deficient manganese to
increase susceptibility.
The relationship between diet, superoxide dismutase activity, and cancer susceptibility offers many promising possibilities that need to be explored. No one has investigated the effect of changes in dietary copper or manganese on chemically induced aberrant crypt formation. The purpose of this study was to investigate the interactive effects of dietary copper, manganese, and iron on DMABP-induced aberrant crypt formation and superoxide dismutase activities.
| MATERIALS AND METHODS |
|---|
|
|
|---|
DMABP was purchased from Toronto Research Chemicals (Toronto, Canada). Peanut oil was obtained from Sigma Chemical (St. Louis, MO.) Methylene blue was purchased from Eastman Kodak (Rochester, NY). Xylazine was purchased from Rompan Mobay (Shawnee, KS) and ketamine from Ketaset Aveco (Fort Dodge, IA).
Experimental design.
The basic design of this study was a 2 x 2 x 2 factorial. The diets contained low or adequate concentrations of copper (by analysis, 0.8 or 5.1 µg Cu/g diet, respectively), low or adequate concentrations of manganese (by analysis, 0.6 or 17 µg Mn/g diet, respectively), and adequate or high concentrations of iron (by analysis, 37 or 140 µg Fe/g diet, respectively). Twelve rats were allowed free access to each of these eight diets for 3.5 wk prior to DMABP administration and for an additional 8 wk after the first DMABP injection.
Animals and diets.
Weanling male Fischer-344 rats were purchased from Sasco (Omaha, NE).
All rats were housed individually in stainless steel, wire-bottomed
cages in a room with controlled temperature and light. They were
provided free access to demineralized water and purified diet. The
formulation of the purified diet was consistent with the AIN-93G diet
(Reeves et al. 1993
). Cupric carbonate, manganese
carbonate, and ferric citrate were added to achieve the
concentrations described above.
After 24 and 31 d of consuming the experimental diets, 10 rats/diet were administered DMABP dissolved in peanut oil (50 g/L) by subcutaneous injection (100 mg/kg body weight). Two additional animals/diet received the comparable vehicle injection of peanut oil only. Animals were killed by exsanguination 8 wk after the first DMABP or vehicle administration.
The study was approved by the Animal Care Committee of the Grand Forks Human Nutrition Research Center, and the animals were maintained in accordance with the National Research Council guidelines for the care and use of laboratory animals.
Sample collection.
Food was withheld overnight before rats were anesthetized with xylazine (Rompan Mobay) and ketamine (Ketaset Aveco) and killed by exsanguination. Blood was collected by cardiac puncture into syringes containing 1 g EDTA/L blood. Kidneys, spleens, and 1-g samples of liver were cleaned of adhering material; weighed; and frozen in liquid nitrogen. Hearts and liver samples were washed with cold 0.9 g NaCl/L and placed in liquid nitrogen. The colon and rectum were removed, flushed with 0.9 g NaCl/L, opened longitudinally, and fixed flat between paper towels in 70% ethanol. The colon and rectum were stored in 70% ethanol at 4°C prior to analysis.
Analysis of ACF.
The fixed colon and rectum were stained with 0.1% methylene blue in
0.1 mol sodium phosphate buffer/L (pH 7.4). ACF and the total number of
aberrant crypts (AC) were scored in a blind fashion by using a
dissecting microscope to visualize the ACF and AC as previously
described (Feng et al. 1996
). The length of the colon
was measured and divided into thirds with the upper third considered as
the ascending colon, the middle third as the transverse colon, and the
bottom third as the descending colon.
Laboratory analysis.
Fresh plasma was analyzed for ceruloplasmin activity by the method of
Schosinsky et al. (1974)
. Plasma and HDL cholesterol concentrations
were determined by using a Cobas Fara automated analyzer (Hoffman La
Roche, Nutley, NJ). Heart and liver total superoxide dismutase activity
were determined by the inhibition of pyrogallol auto-oxidation
(Marklund and Marklund, 1974
). In a second reaction,
KCN (0.1 mmol/L) was added to the reaction mixture to inhibit
copper-zinc superoxide dismutase activity. Copper-zinc
superoxide dismutase activity was calculated as total superoxide
dismutase activity minus manganese superoxide dismutase activity. One
unit of superoxide dismutase activity was defined as the amount of
enzyme needed to obtain 50% inhibition of pyrogallol auto-oxidation.
Samples of liver, kidney, spleen, and colon were analyzed for manganese, iron, copper, and zinc by inductively coupled argon atomic emission spectrometer (Liberty Series II, Varian Associates, Sugarland, TX). Briefly, the tissues were weighed, lyophilized to constant weight, and wet ashed multiple times with nitric acid until most of the organic residue was gone. The charred samples were dissolved in 3 mL nitric acid and 10 mL hydrogen peroxide and heated to dryness on a hotplate. The mineral residue was dissolved in 1 mL of 6 mol HCl/L and diluted appropriately with deionized water. Liver standard reference material (1577b, National Institute of Standards and Technology, Gaithersburg, MD) was analyzed with each batch of tissue samples for quality control. Liver samples (n = 12) were determined to contain 93%, 95%, 101%, and 93% of the certified values for copper, manganese, iron, and zinc, respectively.
Plasma samples were precipitated with 30 g trichloroacetic/L acid and 6 mol HCl/L. The precipitate was analyzed by inductively coupled argon atomic emission spectrometer (Liberty Series II, Varian Associates). Control samples that contained demineralized water, which had been collected through the syringes containing 1 g EDTA/L water and processed in a manner similar to that used for plasma samples, were not found to contain any copper, iron, or zinc contamination.
Statistical analyses.
The data were analyzed by a three-way ANOVA (diet copper, manganese, and iron) using a SAS general linear model program (SAS Version 6.12, SAS Institute, Cary, NC). Tukey's contrasts were used to differentiate among means for variables that had been significantly (P < 0.05) affected by the treatments. Pearson correlations were analyzed to determine the association between superoxide dismutase activity and ACF formation. Values are reported as means ± SEM in the text.
| RESULTS |
|---|
|
|
|---|
Aberrant Crypts.
Aberrant crypt foci were identified in the colon and rectum of rats
administered DMABP. However, no ACF were identified in
vehicle-treated control animals. Most of the ACF were present in
the descending colon; 0, 14.2 ± 2.3, 69.9 ± 3.7, and 17.1
± 3.0% of the ACF were observed in the ascending colon,
transverse colon, descending colon, and rectum, respectively. The
frequency of ACF in the colon plus rectum was significantly higher
(P < 0.0001) in rats fed low dietary copper compared
to those fed adequate dietary copper (1.65 ± 0.29 ACF vs. 3.38
± 0.29, respectively) (Fig. 1
). The number of ACF tended to be higher in rats fed low rather
than adequate dietary manganese (2.76 ± 0.30 vs. 2.25 ± 0.30 ACF, P = 0.09) and in those fed high rather than
adequate dietary iron (2.25 ± 0.30 vs. 1.90 ± 0.30 ACF,
P = 0.11). The frequency of aberrant crypts in the
colon and rectum was also significantly higher (P < 0.00001) in rats fed low dietary copper compared to those fed adequate
dietary copper (Fig. 2
). Similar to the ACF results, the number of AC in the colon and
rectum tended to be higher in rats fed low rather than adequate dietary
manganese (4.68 ± 0.64 vs. 3.60 ± 0.64 AC, P
= 0.09) and in those fed high rather than adequate dietary iron
(5.58 ± 0.64 vs. 4.85 ± 0.64 AC, P = 0.12).
|
|
Hematocrits were 9% lower (0.381 vs. 0.415%, P
< 0.0001), hemoglobin was 10.8% lower (12.9 vs. 14.3 g/L,
P < 0.0001), and ceruloplasmin activity was 492%
lower (6.2 vs. 36.7 U/L, P < 0.0001) in rats fed low
copper than in those fed adequate dietary copper (Table 1
). Rats fed the low manganese diets had significantly depressed
hematocrits and hemoglobin concentrations, but the practical importance
of such small changes in hematocrit and hemoglobin is questionable.
Dietary iron did not significantly affect hematocrit; however, high
dietary iron significantly (P < 0.005) increased
hemoglobin concentrations. Plasma and high density lipoprotein
cholesterol concentrations were significantly higher in rats fed low
rather than adequate dietary copper and in rats fed adequate rather
than low dietary manganese (Table 1)
. Compared to rats fed adequate
dietary copper, rats fed low dietary copper had significantly
(P < 0.0001) lower plasma copper and iron
concentrations and slightly but significantly (P < 0.05) greater plasma zinc concentrations. Dietary manganese and iron
did not significantly affect plasma copper, iron, or zinc
concentrations.
|
All three dietary factors (copper, manganese, and iron) significantly
affected liver CuZnSOD, MnSOD, and total superoxide dismutase
activities (Table 2
). Copper deprivation reduced liver CuZnSOD activity 54% (3.07 vs.
6.69 U/mg protein, P < 0.001) and liver MnSOD activity
by 21% (1.56 vs. 1.97 U/mg protein, P < 0.0001).
In contrast, manganese deprivation significantly (P < 0.0001) increased liver CuZnSOD activity, but significantly
(P < 0.0001) decreased liver MnSOD activity. An
interaction between dietary copper and manganese significantly
(P < 0.0001) affected both liver CuZnSOD and
total superoxide dismutase activities. Similar to low dietary
manganese, high dietary iron caused a significant (P < 0.0001) increase in liver CuZnSOD activity, but a significant
(P < 0.0001) decrease in liver MnSOD activity.
|
The association between superoxide dismutase activity in the liver and
heart and DMABP-induced ACF and AC in the colon and rectum of rats
is shown in Table 3
. Heart CuZnSOD and total superoxide dismutase activity were
significantly (P < 0.0008) correlated with both ACF
and AC formation. In contrast, in the liver CuZnSOD activity was not
significantly correlated with ACF and AC formation; however, hepatic
MnSOD and total superoxide dismutase activity were significantly
(P < 0.05) correlated with AC formation.
|
Liver, kidney, spleen, and colon copper concentrations reflected copper
intakes (Table 4
). Ingestion of low amounts of dietary manganese resulted in lower
(ANOVA, P < 0.01) liver, spleen and colon copper
concentrations. This effect of manganese was not apparent when Tukey's
contrasts were used to compare means. Kidney copper concentrations were
significantly (P < 0.0001) higher in rats fed low
dietary manganese compared to those fed adequate dietary manganese and
in those fed adequate dietary iron compared to high dietary iron. An
interaction between dietary copper and iron affected kidney copper
concentrations; dietary iron affected kidney copper concentrations only
when dietary copper was low. Spleen and colon copper concentrations
were also significantly (P < 0.005) lower in rats fed
high dietary iron compared to those fed adequate dietary iron.
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
In the current study, dietary iron did not significantly affect the
formation of DMABP-induced ACF. Similarly, a recent study by Soyars and Fischer (1998)
observed that dietary iron concentrations that are
~5 and 10 times adequate did not enhance ACF development in the colon
of rats administered azoxymethane. The higher level of ACF observed in
the study by Soyars and Fischer compared to the current study is a
result of the carcinogen being administered. DMABP is a much less
potent carcinogen than dimethylhydrazine or its metabolite,
azoxymethane. In the current study, we utilized DMABP, rather than
dimethylhydrazine or azoxymethane, because of the close similarity
between it and certain mutagens isolated from cooked meat or fish.
One potential mechanism for the protective effect of dietary copper
against DMABP-induced aberrant crypt formation is alterations in
antioxidant enzymes. Two copper containing enzymes, CuZnSOD and
ceruloplasmin, that may help protect against oxygen
radical-mediated injury were significantly reduced in rats fed the
low copper diets. CuZnSOD functions to eliminate superoxide radicals,
and ceruloplasmin is hypothesized to inhibit iron-catalyzed radical
formation (Fridovich 1975
, Gutteridge and
Halliwell 1988
). Substantial evidence has suggested
that free radicals, particularly oxygen radicals, are involved in both
the initiation and promotion stages of carcinogenesis (Sun 1990
). Much of the evidence has come from the fact that
antioxidants that scavenge free radicals directly, or that interfere
with the generation of free radical-mediated events, inhibit the
neoplastic process and that the activities of antioxidant enzymes are
changed during tumor formation (Sun 1990
). For example,
when compared to their normal cell counterparts, tumor cells are always
low in MnSOD and usually low in CuZnSOD activity (Marlens et al. 1985
, McCormick et al. 1991
, Oberley et al. 1978
, Sun 1990
, Sun et al. 1993
).
Although altered antioxidant enzymes were found in many tumors, it is
unknown whether this abnormality is one of the causes of cancer or if
it is just one of the consequences of the carcinogenic process. Van Driel et al. (1997)
found that colorectal carcinomas were characterized
immunohistochemically by decreased amounts of CuZnSOD and MnSOD and
total superoxide dismutase activity when compared to adjacent normal
mucosa. However, quantitative differences in expression of CuZnSOD and
MnSOD or superoxide dismutase activity were not detected between
adenomas of the colon and normal adjacent mucosa (Van Driel et al. 1997
). This suggests that decreased superoxide dismutase
expression may occur at a later stage of the carcinogenic process. In
contrast, overexpression of superoxide dismutase was shown to inhibit
malignant transformation (Oberley and Oberley 1997
,
Petkau et al. 1975
, St. Clair et al. 1992
). This suggests that decreased superoxide dismutase
expression may occur prior to initiation.
In the current study, we investigated whether alterations in dietary copper, manganese, and iron, which would affect both CuZnSOD and MnSOD activities, would be associated with the formation of ACF, an early step in the carcinogenic process. Heart CuZnSOD and total superoxide dismutase activity were significantly correlated with both DMABP-induced ACF and AC formation. The lowest number of aberrant crypt foci and total aberrant crypts were observed in the rats fed adequate dietary copper and adequate dietary manganese, and the highest number of aberrant crypt foci and total aberrant crypts were observed in those fed low dietary copper and low dietary manganese. Similarly, the highest heart total superoxide dismutase activity was observed in the rats fed adequate dietary copper and manganese, and the lowest heart superoxide dismutase activity was observed in those fed low dietary copper and manganese. These findings suggest that dietary alterations that affect superoxide dismutase activity will affect cancer susceptibility. However, heart and liver superoxide dismutase activities responded differently to the dietary changes. In contrast to the results observed in the heart, the highest liver total superoxide dismutase activity was observed in the rats fed adequate dietary copper and low dietary manganese, and the lowest liver total superoxide dismutase activity was observed in those fed low dietary copper and adequate dietary manganese. Therefore, in future studies, superoxide dismutase activity should be measured in the colon, particularly the epithelial cells, the target organ for DMABP-induced carcinogenesis because measurement of antioxidant enzyme biochemical activities in whole organs or tissues does not provide an estimate of enzyme activities of individual cell types within these organs or tissues from which the tumors develop.
In conclusion, ACF, which are a preneoplastic lesion of colon cancer,
were used as a biomarker to measure the effect of dietary copper,
manganese, and iron on aromatic amine-induced colon carcinogenesis.
Low dietary copper significantly increased and low dietary manganese
tended to increase the formation of DMABP-induced ACF and AC.
Similarly, the highest heart total superoxide dismutase activity was
observed in the rats fed adequate dietary copper and manganese, and the
lowest heart superoxide dismutase activity was observed in those fed
low dietary copper and manganese. These findings suggest that dietary
alterations that affect superoxide dismutase activity may affect cancer
susceptibility. Furthermore, the effect of dietary copper and manganese
on ACF formation may have practical implications because diets in the
United States often contain less copper and manganese than the
estimated safe and adequate daily dietary intake for copper and
manganese (Davis et al. 1992b
, Klevay and Medeiros 1996
).
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 The US Department of Agriculture, Agricultural
Research Service, Northern Plains Area, is an equal
opportunity/affirmative action employer, and all agency services are
available without discrimination. ![]()
4 Abbreviations used: AC, aberrant crypts; ACF,
aberrant crypt foci; CuZnSOD, copper-zinc superoxide dismutase;
DMABP, 3,2'-dimethyl-4-aminobiphenyl; MnSOD, manganese superoxide
dismutase. ![]()
Manuscript received November 9, 1998. Initial review completed December 10, 1998. Revision accepted January 12, 1999.
| REFERENCES |
|---|
|
|
|---|
1. Bird R. P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings. Cancer Lett 1987;37:147-151[Medline]
2. Bird R. P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 1995;93:55-71[Medline]
3. Cancer Facts and Figures.(1997)American Cancer Society, Atlanta, GA.
4.
Davis C. D., Greger J. L. Longitudinal changes of manganese-dependent superoxide dismutase and other indexes of manganese and iron status in women. Am. J. Clin. Nutr. 1992;55:747-752
5.
Davis C. D., Malecki E. A., Greger J. L. Interactions among dietary manganese, heme iron, and nonheme iron in women. Am. J. Clin. Nutr. 1992;56:926-932
6. Davis C. D., Ney D. M., Greger J. L. Manganese, iron and lipid interactions in rats. J. Nutr. 1990;120:507-513
7. Davis C. D., Wolf T. L., Greger J. L. Varying levels of manganese and iron affect absorption and gut endogenous losses of manganese by rats. J. Nutr. 1992;122:1300-1308
8. DiSilvestro R. A., Greenson J. K., Liao Z. Effects of low copper intake on dimethylhydrazine-induced colon cancer in rats. Proc. Soc. Exp. Biol. Med. 1992;201:94-97[Abstract]
9.
Feng Y., Wagner R. J., Fretland A. J., Becker W. K., Cooley A. M., Pretlow T. P., Lee K. J., Hein D. W. Acetylator genotype (NAT2)-dependent formation of aberrant crypts in congenic Syrian hamsters administered 3,2'-dimethyl-4-aminobiphenyl. Cancer Res 1996;56:527-531
10.
Fiala E. S., Weisburger J. H., Katayama S., Chandrasekaran V., Williams G. M. Effect of disulfiram on the carcinogenicity of 3,2'-dimethyl-4-aminobiphenyl in Syrian golden hamsters and rats. Carcinogenesis 1981;2:965-969
11. Fridovich I. Superoxide dismutases. Annu. Rev. Biochem. 1975;44:147-159[Medline]
12. Greene F. L., Lamb L. S., Barwick M., Pappas N. J. Effect of dietary copper on colonic tumor production and aortic integrity in the rat. J. Surg. Res. 1987;42:503-512[Medline]
13. Gutteridge J. M., C & Halliwell B. The antioxidant proteins of extracellular fluids. Chow C. K. eds. Cellular Antioxidant Defense Mechanisms 1988;vol. II:1-23 CRC Press Boca Raton, FL.
14. Klevay L. M., Medeiros D. M. Deliberations and evaluations of the approaches, endpoints and paradigms for dietary recommendations about copper. J. Nutr. 1996;126:2419S-2426S
15. Konstantakos A. K., Siu I. M., Pretlow T. G., Stellato T. A., Pretlow T. P. Human aberrant crypt foci with carcinoma in situ from a patient with sporadic colon cancer. Gastroenterology 1996;111:772-777[Medline]
16. Kuratko C. N. Increasing dietary lipid and iron content decreases manganese superoxide dismutase activity in colonic mucosa. Nutr. Cancer 1997;28:36-40[Medline]
17. Lai C., Dunn D. M., Miller M. F., Pence B. C. Non-promoting effects of iron from beef on the rat colon carcinogenesis model. Cancer Lett 1997;112:87-91[Medline]
18. Lang N. P., Butler M. A., Massengell J., Lawson M., Stotts R. C., Hauer-Jensen M., Kadlubar F. F. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increases the risk of colorectal cancer or polyps. Cancer Epidemiol. Biomarkers Prev. 1994;3:675-682[Abstract]
19. Marklund S., Marklund G. Involvement of the superoxide anion in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 1974;47:469-474[Medline]
20. Marlens F., Nicole A., Sinet P. M. Lowered level of translatable messenger RNAs for manganese superoxide dismutase in human fibroblasts transformed by SV40. Biochem. Biophys. Res. Commun. 1985;129:300-305[Medline]
21.
McCord J. M., Fridovich I. Superoxide dismutase: An enzymatic function for erythrocuprein (hemocruprein). J. Biol. Chem. 1969;244:6049-6055
22.
McCormick M. L., Oberley T. D., Elwell J. H., Oberley L. W., Sun Y., Li J. J. Superoxide dismutase and catalase levels in renal tumors and their autonomous variants in the Syrian hamster. Carcinogenesis 1991;12:977-983
23.
Nelson R. G., Davis F. G., Sutter E., Sobin L. H., Kikendall J. W., Bowen P. Body iron stores and risk of colonic neoplasis. J. Natl. Cancer Inst. 1994;86:455-460
24. Niedereau C., Fischer R., Sonnenberg A., Stremmel W., Trampisch H. J. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hematochromatosis. N. Engl. J. Med. 1985;313:1256-1262[Abstract]
25. Oberley L. W., Bize I. B., Sahu S. K., Leuthauser S.W., H & Gruber H. E. Superoxide dismutase activity of normal murine liver, regenerating liver and H6 hepatoma. J. Natl. Cancer Inst. 1978;61:375-379
26. Oberley T. D., Oberley L. W. Antioxidant enzyme levels in cancer. Histol. Histopathol. 1997;12:525-535[Medline]
27.
Pereira M. A., Barnes L. H., Rassman V. L., Kelloff G. V., Steele V. E. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis 1994;15:1049-1054
28. Petkau A., Chelack W. S., Pleskach S. D., Meeker B. E., Brady C. M. Radioprotection of mice by superoxide dismutase. Biochem. Biophys. Res. Comm. 1975;65:886-893[Medline]
29.
Pretlow T. P., O'Rioridan M. A., Somich G. A., Amini S. B., Pretlow T. G. Aberrant crypts: Putative preneoplastic foci in human colonic mucosa. Cancer Res 1991;51:1564-1567
30. Reeves P. G., Nielsen F. H., Fahey G. C. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993;123:1939-1951
31. Reizenstein P. Iron, free radicals and cancer. Med. Oncol. Tumor Pharmacother. 1991;8:229-233[Medline]
32. Schoskinsky K. H., Lehmann H. P., Beeler M. F. Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin. Chem. 1974;20:1556-1563[Abstract]
33.
Shirai T., Nakamura A., Fukushima S., Yamamoto A., Tada M., Ito N. Different carcinogenic responses in a variety of organs, including the prostate, of five different rat strains given 3,2'-dimethyl-4-aminobiphenyl. Carcinogenesis 1990;11:793-797
34. Siu I.-M., Pretlow T. G., Amini S. B., Pretlow T. P. Identification of dysplasia in human colonic aberrant crypt foci. Am. J. Path. 1997;150:1805-1813[Abstract]
35.
Soyars K. E., Fischer J. G. Iron supplementation does not affect cell proliferation or aberrant crypt foci development in the colon of Sprague-Dawley rats. J. Nutr. 1998;128:764-770
36. St. Clair D. K., Wan X. S., Oberley T. D., Muse K. E., St. Clair W. H. Suppression of radiation-induced neoplastic transformation by overexpression of mitochondrial superoxide dismutase. Mol. Carcinogenesis 1992;6:238-242[Medline]
37. Sun Y. Free radicals, antioxidant enzymes and carcinogenesis. Free Radic. Biol. Med. 1990;16:275-282
38. Sun Y., Li Y., Oberley L. W. Superoxide dismutase activity during dimethylhydrazine colon carcinogenesis and the effect of cholic acid and indole. Free Radical Res. Commun. 1993;4:299-310
39. Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic. Biol. Med. 1996;4:553-566
40.
Tseng M., Murray S. C., Kupper L. L., Sandler R. S. Micronutrients and the risk of colorectal adenomas. Am. J. Epidemiol. 1996;144:1005-1014
41. Ullen H., Augustsson K., Gustavsson C., Steineck G. Supplementary iron intake and risk of cancer: reversed causality?. Canc. Lett. 1997;114:215-216
42. Van Driel B.E.M, Lyon H., Hoogenraad D.C.J, Anten S., Hansen U., Van Noorden C.J.F. Expression of CuZn- and Mn-superoxide dismutase in human colorectal neoplasms. Free Radic. Biol. Med. 1997;23:435-444[Medline]
43.
Weisiger R. A., Fridovich I. Superoxide dismutase, organelle specificity. J. Biol. Chem. 1973;248:4793-4796
44. Zhao M., Matter K., Laissue J. A., Zimmerman A. Copper/zinc and manganese superoxide dismutase immunoreactivity in hepatic iron overload diseases. Histol. Histopathol. 1995;10:925-935[Medline]
This article has been cited by other articles:
![]() |
E. O. Uthus, P. G. Reeves, and J. T. Saari Copper Deficiency Decreases Plasma Homocysteine in Rats J. Nutr., June 1, 2007; 137(6): 1370 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Saari, P. G. Reeves, W. T. Johnson, and L. K. Johnson Pinto Beans Are a Source of Highly Bioavailable Copper in Rats J. Nutr., December 1, 2006; 136(12): 2999 - 3004. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Reeves, N. V. C. Ralston, J. P. Idso, and H. C. Lukaski Contrasting and Cooperative Effects of Copper and Iron Deficiencies in Male Rats Fed Different Concentrations of Manganese and Different Sources of Sulfur Amino Acids in an AIN-93G-Based Diet J. Nutr., February 1, 2004; 134(2): 416 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Pierre, S. Tache, C. R. Petit, R. Van der Meer, and D. E. Corpet Meat and cancer: haemoglobin and haemin in a low-calcium diet promote colorectal carcinogenesis at the aberrant crypt stage in rats Carcinogenesis, October 1, 2003; 24(10): 1683 - 1690. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Davis Low Dietary Copper Increases Fecal Free Radical Production, Fecal Water Alkaline Phosphatase Activity and Cytotoxicity in Healthy Men J. Nutr., February 1, 2003; 133(2): 522 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Lund, S. J. Fairweather-Tait, S. G. Wharf, and I. T. Johnson Chronic Exposure to High Levels of Dietary Iron Fortification Increases Lipid Peroxidation in the Mucosa of the Rat Large Intestine J. Nutr., November 1, 2001; 131(11): 2928 - 2931. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||